Pharmaceutical companies have long experience in measuring the impact of their business programs. The same should apply to their access-to-medicine efforts
Richard Laing, from the Boston University (BU) School of Public Health and former World Health Organization official, says that many efforts to expand access to medicines fail to gather sufficient evidence on how effective they are. His team at BU recently issued a study highlighting these gaps, and emphasizing the need for companies to better document the impact of their programs.
We’re proud to announce a new philanthropic partnership with the American Diabetes Association (Association). A collaboration between positiveNRG and NRG’s Human Resources team, our partnership with the Association realizes the positiveNRG pillar of health and wellness with the goal of helping to both prevent and delay diabetes while improving the quality of life for those affected by the disease.
Making our cities into places of wellbeing, exciting growth and opportunity will require every sector to join forces on urban health, says Dr. Ann Aerts, Head of the Novartis Foundation.
By Dr. Ann Aerts, Head of the Novartis Foundation
Walking through the wealthier streets of cities like Geneva, London or New York, it seems that health and fitness is an international obsession. National food chains boast of fresh ingredients, light options, and low-fat meals. Shelves are stacked with the trendiest superfoods – quinoa, chia seeds, kale and avocado.
Better Hearts Better Cities is an initiative to improve cardiovascular health in low-income urban communities by addressing the prevention, management and control of hypertension
Better Hearts Better Cities is a Novartis Foundation initiative to improve cardiovascular health in low-income urban communities by addressing the prevention, management and control of hypertension.
Non-communicable diseases (NCDs), including cardiovascular disease, are a growing health crisis with 75% of NCD deaths occurring in low- and middle-income countries; this is compounded by rapid urbanization.
The innovative approach is being tested on three continents: in Mongolia, Senegal, and Brazil.
Novartis reaches agreement with Pakistan to supply medicines that address the rapid rise of chronic illness among poor people in the world's sixth most populous nation.
May 12, 2017 /3BL Media/ -- We are pleased to announce that Novartis and the Ministry of National Health Services, Regulation and Coordination of the Islamic Republic of Pakistan have signed a Memorandum of Understanding to implement Novartis Access in Pakistan. Novartis Access medicines will be made available to the poorest population through hospitals under the Prime Minister’s National Health Insurance Program.
Employee volunteers at De Beers’ Venetia mine in South Africa have raised cash for the fight against cancer by having their hair sprayed or shaved.
Around 1,000 people from De Beers and contracting firms stepped forward to face the scissors or the spray for the mine’s annual CANSA Shavathon.
The mine’s volunteer ‘diamond ambassadors’ did the shaving and spraying for fellow employees who each paid R30 (US$2.32) for the privilege. Some had their hair sprayed in stripes or shapes, using stencils.
Family-friendly walk or run pays tribute to cancer survivors
AUSTIN, Texas, April 27, 2017 /3BL Media/ – In celebration of its 20th Anniversary, the LIVESTRONG Foundation – a global leader and pioneer in cancer patient survivorship – announced today the launch of The LIVESTRONG Honor 5k/10k, which will take place on September 17 in downtown Austin. Participants are encouraged to wear commemorative bibs featuring the name of a “Cancer Warrior” in honor of the brave, inspiring survivors of the life-threatening disease.
FOSTER CITY, Calif., May 1, 2017 /3BL Media/ - Gilead Sciences, Inc. today announced that it issued its Year in Review 2016 report, a combination of the company’s Annual Report and Corporate Social Responsibility report. This report provides an in-depth look into Gilead’s commitment to develop and deliver innovative therapies that change lives.
The report focuses on four key areas: giving and access, people, products and environment as well as a financial overview. Highlights include:
CAMBRIDGE, Mass., April 18, 2017 /3BL Media/ -- PatientsLikeMe and Shire plc have announced a new collaboration that will support the development of a patient-centered, real world health learning system that expands understanding of patient health and disease. Philip Vickers, PhD, Head of Research and Development for Shire, said working with PatientsLikeMe will help the company overcome some of the traditional challenges inherent in understanding rare diseases.